This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Kinsey C, et al. Myc amplification is a negative biomarker and a resistance mechanism to trametinib/HCQ treatment, but can be overcome by combined palbociclib/HCQ treatment. Cancer Research 79 (Suppl.): abstr. C30, No. 24, Dec 2019. Available from: URL: https://cancerres.aacrjournals.org/content/79/24_Supplement/C30 [abstract]